SeaBridge Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.63M Buy
23,819
+150
+0.6% +$51.3K 1.25% 23
2026
Q1
$8.33M Buy
23,669
+3,929
+20% +$1.4M 1.41% 18
2025
Q4
$6.46M Sell
19,740
-268
-1% -$85K 1.07% 27
2025
Q3
$5.65M Buy
20,008
+808
+4% +$234K 0.92% 32
2025
Q2
$5.36M Sell
19,200
-3,432
-15% -$972K 1% 27
2025
Q1
$7.05M Buy
22,632
+698
+3% +$206K 1.52% 15
2024
Q4
$5.72M Sell
21,934
-2,865
-12% -$850K 1.2% 22
2024
Q3
$7.99M Sell
24,799
-108
-0.4% -$35.3K 1.96% 10
2024
Q2
$7.78M Buy
24,907
+7,655
+44% +$2.25M 2.02% 10
2024
Q1
$4.91M Buy
17,252
+387
+2% +$113K 1.29% 19
2023
Q4
$4.86M Buy
16,865
+4
+0% +$1.09K 1.41% 14
2023
Q3
$4.53M Buy
16,861
+389
+2% +$97.1K 1.49% 12
2023
Q2
$3.66M Buy
16,472
+360
+2% +$83.5K 1.2% 20
2023
Q1
$3.9M Sell
16,112
-105
-0.6% -$25.8K 1.36% 17
2022
Q4
$4.26M Sell
16,217
-728
-4% -$195K 1.52% 17
2022
Q3
$3.82M Sell
16,945
-270
-2% -$65.4K 1.33% 21
2022
Q2
$4.19M Buy
17,215
+1,109
+7% +$272K 1.35% 15
2022
Q1
$3.9M Sell
16,106
-397
-2% -$91.2K 1.16% 21
2021
Q4
$3.71M Sell
16,503
-1,600
-9% -$338K 1.19% 24
2021
Q3
$3.85M Buy
18,103
+63
+0.3% +$14.5K 1.26% 22
2021
Q2
$4.4M Sell
18,040
-531
-3% -$131K 1.42% 19
2021
Q1
$4.62M Buy
18,571
+266
+1% +$63.5K 1.53% 20
2020
Q4
$4.21M Buy
18,305
+47
+0.3% +$10.8K 1.52% 18
2020
Q3
$4.64M Sell
18,258
-65
-0.4% -$16.1K 1.73% 12
2020
Q2
$4.32M Buy
18,323
+5,415
+42% +$1.24M 1.68% 12
2020
Q1
$2.62M Buy
12,908
+35
+0.3% +$7.64K 1.2% 30
2019
Q4
$3.1M Sell
12,873
-2,562
-17% -$565K 1.08% 34
2019
Q3
$2.99M Buy
15,435
+62
+0.4% +$11.9K 1.02% 39
2019
Q2
$2.83M Sell
15,373
-135
-0.9% -$24.2K 0.94% 43
2019
Q1
$2.95M Sell
15,508
-93
-0.6% -$17.8K 0.98% 41
2018
Q4
$3.04M Buy
15,601
+346
+2% +$67.5K 1.1% 34
2018
Q3
$3.16M Sell
15,255
-879
-5% -$173K 0.81% 47
2018
Q2
$2.98M Sell
16,134
-2,497
-13% -$442K 0.73% 54
2018
Q1
$3.18M Sell
18,631
-122
-0.7% -$22.4K 0.71% 55
2017
Q4
$3.26M Buy
18,753
+108
+0.6% +$19.1K 0.71% 57
2017
Q3
$3.48M Sell
18,645
-254
-1% -$45K 0.81% 48
2017
Q2
$3.25M Sell
18,899
-313
-2% -$50.9K 0.78% 49
2017
Q1
$3.15M Sell
19,212
-1,700
-8% -$282K 0.76% 51
2016
Q4
$3.06M Sell
20,912
-5,853
-22% -$881K 0.73% 50
2016
Q3
$4.46M Sell
26,765
-30
-0.1% -$5.07K 1.11% 34
2016
Q2
$4.08M Sell
26,795
-862
-3% -$134K 1.03% 38
2016
Q1
$4.15M Sell
27,657
-2,782
-9% -$413K 1.01% 39
2015
Q4
$4.94M Buy
30,439
+1,827
+6% +$287K 1.1% 38
2015
Q3
$3.96M Buy
28,612
+1,760
+7% +$277K 0.92% 45
2015
Q2
$4.12M Buy
26,852
+881
+3% +$141K 0.84% 48
2015
Q1
$4.15M Buy
25,971
+959
+4% +$151K 0.84% 48
2014
Q4
$3.98M Buy
25,012
+24,912
+24,912% +$3.88M 0.82% 48
2014
Q3
$14K Hold
100
﹤0.01% 183
2014
Q2
$12K Buy
+100
New +$11.6K ﹤0.01% 203

Other funds holding AMGN

SeaBridge Investment Advisors's AMGN Position: Q2 2026 in Review

SeaBridge Investment Advisors increased its Amgen (AMGN) stake by 0.63% in Q2 2026, buying an estimated $51.3K and bringing the position to 23,819 shares worth $8.63M. The position accounts for 1.25% of the portfolio, ranked #23.

SeaBridge Investment Advisors first reported a position in AMGN in Q2 2014 and has held it in 49 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SeaBridge Investment Advisors held 23,819 shares of Amgen worth $8.63M as of Q2 2026.
  • SeaBridge Investment Advisors bought 150 Amgen shares in Q2 2026, an estimated $51.3K.
  • Amgen made up 1.25% of SeaBridge Investment Advisors's portfolio in Q2 2026, its #23 holding.
  • SeaBridge Investment Advisors first reported a position in Amgen in Q2 2014 and has held it in 49 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SeaBridge Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.